By evaluating the expression of these genes in high- and low-risk tumors in a dataset of 498 RNAseq data (GEO ID: GSE62564), we found that GSKIP is upregulated in high-risk NB patients, whereas ZMYM1 and CBL are upregulated in low-risk patients. The gene discussed is CBL; the disease is neuroblastoma.